Influenza Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Influenza Tests Market Overview

The influenza tests market size was valued at $367.3 million in 2022. Influenza tests are diagnostic tests used to detect the presence of the influenza virus in a patient’s respiratory system. The choice of an influenza test depends on a variety of factors, including the severity of the patient’s illness, the timing of the test, and the availability of testing facilities. This segment includes Influenza Antigen Tests, Influenza Multiplex NAATs, and Influenza Lowplex Nucleic Acid Amplification Tests (NAATs). One unit refers to One Influenza test.

Influenza Tests Market Outlook, 2022-2033 ($ Million)

Influenza Tests Market Outlook, 2022-2033 ($ Million)

For more insights on the influenza tests market forecast, download a free report sample

Influenza tests market research report is built to visualize quantitative market trends within In Vitro therapeutic area. It discusses in detail the impact of COVID-19 on the influenza tests market for the year 2020 and beyond.

Market Size (2022) $367.3 million
Forecast Period 2022-2033
Historical Period 2015-2021
Key Regions ·       North America

·       Europe

·       Asia Pacific

·       South Central America

·       Middle East and Africa

Key Segments ·       Influenza Multiplex NAATs

·       Influenza Antigen Tests

·       Influenza Lowplex Nucleic Acid Amplification Tests (NAATs)

Influenza Tests Market Dynamics

Epidemic influenza causes global public health burden each season. The World Health Organization (WHO) estimates that influenza severely affects between three and five million individuals each year and causes between 250,000 and 500,000 deaths. The influenza attack rate is highest in children, while complications including hospitalization and death occur most frequently in elderly individuals.

Influenza testing is done through three primary PCR tests: Lowplex NAATs, Antigen Tests (including Enzyme Immunoassays, Fluorescence Immunoassays, and Direct Fluorescence detection methods), and Multiplex NAATs. Although, NAATs holds a significant market share and will remain the gold standard of testing due to its established and widespread use, POC Antigen and POC NAAT tests are gaining traction. GlobalData expects Multiplex NAATs to gain in usage with the approach of successive flu seasons, and physician and patient preference will likely be given to such respiratory panels. .

Influenza Tests Market Segmentation by Regions

The key regions in the influenza tests market are North America, Europe, Asia Pacific, South America, and the Middle East & Africa. North America held the largest market share in 2022. The Influenza tests market is expected to grow in Canada and Mexico and decline in the US during the forecast period.

Growth of the Canadian Influenza test markets is largely being driven by increases in the number of incident cases and the number of suspected and confirmatory cases opting for Influenza tests. Sales of Influenza tests in the US are expected to decline at a minor rate due to a decrease in the number of incident cases.

Influenza Tests Market Segments

The key segments in the influenza tests market are Influenza Antigen Tests, Influenza Multiplex NAATs, and Influenza Lowplex Nucleic Acid Amplification Tests (NAATs). Influenza Multiplex NAATs led the market in 2022.

Influenza Tests Market Analysis, by Segments 2022 (%)

Influenza Tests Market Analysis, by Segments 2022 (%)

To know more about the key segments in the influenza tests market, download a free report sample

Influenza Tests Market - Competitive Landscape

Some of the leading companies in the influenza tests market are Abbott Laboratories, Quidel Corp, Cepheid Inc, DiaSorin SpA, bioMerieux SA, Becton Dickinson and Co, and Qiagen NV. Abbott Laboratories dominated the market in 2022.

Influenza Tests Market Analysis, by Companies 2022 (%)

Influenza Tests Market Analysis, by Companies 2022 (%)

To know more about the leading companies in the influenza tests market, download a free report sample

Segments Covered in the Report

Influenza Tests Market Segments Outlook (Value, $ Million, 2015-2033)

  • Influenza Multiplex NAATs
  • Influenza Antigen Tests
  • Influenza Lowplex Nucleic Acid Amplification Tests (NAATs)

Influenza Tests Market Regional Outlook (Value, $ Million, 2015-2033)

  • North America
  • Europe
  • Asia Pacific
  • South Central America
  • Middle East and Africa

Key Inclusions

Currently marketed Influenza Test and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total influenza tests market revenue by segment and market outlooks from
    2015– 2033.
  • Market-level data on units, average selling prices, and market values.

Global, Regional, and Country level market specific insights:

  • Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for influenza tests market.
  • Competitive dynamics insights and trends provided for the influenza tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country-specific overview of the healthcare system.
  • Country-specific reimbursement policies.
  • Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Danaher Corp, Quidelortho Corp, F. Hoffmann-La Roche Ltd, DiaSorin SpA, Becton Dickinson and Co, Qiagen NV, Thermo Fisher Scientific Inc, bioMerieux SA, Sekisui Diagnostics LLC, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.


This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

  • CMO executives who must have deep understanding of the influenza tests market place to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets

Reasons to Buy

The model will enable you to:

  • Understand the impact of COVID-19 on the influenza tests market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the influenza tests market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the influenza tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific influenza tests market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Frequently asked questions

Influenza Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 thematic reports
Currency USD

Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Influenza Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Influenza Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 in real time.

  • Access a live Influenza Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.